The association between depression and health-related quality of life in people with type 2 diabetes: A systematic literature review

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 2, 2010, Pages 75-89

  Ali, Saima ^a   Stone, Margaret ^b   Skinner, Timothy Chas ^c   Robertson, Noelle ^b   Davies, Melanie ^b   Khunti, Kamlesh ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Depression; Health related quality of life; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; EMBASE; HUMAN; MEDLINE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCINFO; QUALITY OF LIFE; REVIEW; SELF REPORT; SYSTEMATIC REVIEW;

ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 2; HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 77950447519     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1065     Document Type: Review

References (63)

1. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type 1 and type 2 diabetes. Diabetes Care 1994; 17(4): 267-274.
2. Gåfvels C, Lithner F, Börjeson B. Living with diabetes: relationship to gender, duration and complications. A survey in northern Sweden. Diabet Med 1993; 10(8): 768-773.
3. Kleefstra N, Landman GW, Houweling ST, et al. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4). Diabetes Care 2008; 31: 932-933.
4. Eiser C, Morse R. The history and scope of quality-of-life measurement for children. Health Technol Assess 2001; 5: 1-7.
5. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum 2000; 13(1): 36.
6. Atkinson M, Zibin S, Chuang H. Characterising quality of life among patients with chronic illness: a critical examination of the self-report methodology. Am J Psychiatry 1997; 154: 99-105.
7. Jenkins CD. Assessment of outcomes of health intervention. Soc Sci Med 1992; 35(4): 367-375.
8. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metabol Res Rev 1999; 15: 205-218.
9. Jacobson AM. Quality of life in patients with diabetes mellitus. Semin Clin Neuropsychiatry 1997; 2(1): 82-93.
10. Patrick DL, Bergner M. Measurement of health status in the 1990s. Annu Rev Public Health 1990; 11: 165-183.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622-629.
12. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995; 273(1): 59-65.
13. Bradley C. Importance of differentiating health status from quality of life. Lancet 2001; 357(9249): 7-8.
14. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA 1997; 278(1): 47-50.
15. Speight J, Reaney MD, Barnard KD. Not all roads lead to Rome - a review of quality of life measurement in adults with diabetes. Diabet Med 2009; 26(4): 315-327.
16. Mandelblatt JS, Siegel JE, Russell LB, et al. Assessing the effectiveness of health interventions. In Cost-Effectiveness in Health and Medicine, Gold MR, Fryback DG, Weinstein MC, et al. (eds). Oxford University Press: New York, 1996; 135-175.
17. Gold M, Franks P, Erickson P. Assessing the health of the nation: the predictive validity of a preference-based measure of self-rated health. Med Care 1996; 34(2): 163-177.
18. Ryan M, Scott DA, Reeves C, et al. Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess 2001; 5(5): 1-186.
19. Luscombe FA. Health-related quality of life measurement in type 2 diabetes. Value Health 2000; 3(Suppl 1): 15-28.
20. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24(6): 1069-1078.
21. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2007; 23(11): 1165-1173.
22. Kudielka BM, von Känel R, Gander ML, et al. The interrelationship of psychosocial risk factors for coronary artery disease in a working population: do we measure distinct or overlapping psychological concepts? Behav Med 2004; 30: 35-43.
23. Redekop WK, Koopmanschap MA, Stolk RP, Rutten GE, Wolffenbuttel BH, Niessen LW. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care 2002; 25(3): 458-463.
24. Coffey JT, Brandle M, Zhou H, et al. Valuing health-related quality of life in diabetes. Diabetes Care 2002; 25: 2283-12243
25. Anderson R, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069-1078.
26. UK Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999; 22: 1125-1136.
27. World Health Organisation Europe and International Diabetes Federation Europe. Diabetes care and research in Europe: The St Vincent declaration. Diabet Med 1990; 7: 360.
28. Richter B, Bergerhoff K, Paletta G, et al. Metabolic and Endocrine Disorders Group. The Cochrane Library (Issue 1). Wiley: Chichester, UK, 2004.
29. Mallen C, Peat G, Croft P. Quality assessment of observational studies is not commonplace in systematic reviews. J Clin Epidemiol 2006; 59: 765-769.
30. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-2012.
31. Undertaking systematic reviews of research on effectiveness: CRD's guidance for carrying out or commissioning reviews. In CRD Report (4) (2nd ed). NHS Centre for Reviews and Dissemination: York, UK, 2001.
32. Pawaskar MD, Anderson RT, Balkrishnan R. Self-reported predictors of depressive symptomatology in an elderly population with type 2 diabetes mellitus: a prospective cohort study. Health Qual Life Outcomes 2007; 5: 50.
33. Von Korff M, Katon W, Lin EH, et al. Potentially modifiable factors associated with disability among people with diabetes. Psychosom Med 2005; 67(2): 233-240.
34. Sundaram M, Kavookjian J, Patrick JH, Miller LA, Madhavan SS, Scott VG. Quality of life, health status and clinical outcomes in type 2 diabetes patients. Qual Life Res 2007; 16(2): 165-177 [Erratum appears in Qual Life Res 2007; 16(5): 907].
35. Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB. The relationship of depressive symptoms to symptom reporting, selfcare and glucose control in diabetes. Gen Hosp Psychiatry 2003; 25(4): 246-252.
36. Kaholokula JK, Haynes SN, Grandinetti A, Chang HK. Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behav Med 2003; 26(5): 435-458.
37. Hanninen JA, Takala JK, Keinanen-Kiukaanniemi SM. Depression in subjects with type 2 diabetes: predictive factors and relation to quality of life. Diabetes Care 1999; 22(6): 997-998.
38. Chyun DA, Melkus GD, Katten DM, et al. The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs 2006; 7(4): 279-288.
39. Caruso LB, Silliman RA, Demissie S, Greenfield S, Wagner EH. What can we do to improve physical function in older persons with type 2 diabetes? J Gerontol A Biol Sci Med Sci 2000; 55(7): M372-M377.
40. Pibernik-Okanovic M, Peros K, Szabo S, Begic D, Metelko Z. Depression in Croatian Type 2 diabetic patients: prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium. Diabet Med 2005; 22(7): 942-945.
41. Kaholokula JK, Haynes SN, Grandinetti A, Chang HK. Ethnic differences in the relationship between depressive symptoms and health-related quality of life in people with type 2 diabetes. Ethn Health 2006; 11(1): 59-80.
42. Maddigan SL Feeny DH, Majumdar SR, Farris KB, Johnson JA. Understanding the determinants of health for people with type 2 diabetes. Am J Public Health 2006; 96(9): 1649-1655.
43. Wexler DJ, Grant RW, Wittenberg E, et al. Correlates of health-related quality of life in type 2 diabetes. Diabetologia 2006; 49(7): 1489-1497.
44. Gaynes BN, Burns BJ, Tweed DL, Erickson P. Depression and health-related quality of life. J Nerv Ment Dis 2002; 190(12): 799-806.
45. Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 2001; 24(10): 1751-1757.
46. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160(21): 3278-3285.
47. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34(3): 220-233.
48. Horsman J, Furlong W, Feeny D, Torrance G. The Health Utilities Index (HUI®): concepts, measurement properties and applications. Health Qual Life Outcomes 2003; 1: 54.
49. Gold M, Franks P, Erickson P. Assessing the health of the nation: the predictive validity of a preference-based measure and self-rated health. Med Care 1996; 34: 163-177.
50. Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the WHO Disability Assessment Schedule (WHO-DAS-II) in a primary care setting. J Clin Epidemiol 2003; 56: 507-514.
51. Jacobson AM. Diabetes Control and Complications Trial and R. Group. The diabetes quality of life measure. In Handbook of Psychology and Diabetes., Bradley C (ed). Harwood Academic: Chur, Switzerland, 1994.
52. Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individualized Questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91.
53. Drummond M. Introducing economic and quality of life measurements into clinical studies. Ann Intern Med 2001; 33: 344-349.
54. Cohen B, Barbano HE, Cox CS, et al. Plan and operation of the NHANES I epidemiologic followup study: 1982-1984. Vital Health Stat Ser 1987; 1(22): 1-142.
55. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-263.
56. Kohen D, Burgess AP, Catalán J, Lant A. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res 1998; 7(3): 197-204.
57. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-630.
58. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994; 47: 81-87.
59. Costa PT, McRae RR. Hypochondriasis, neuroticism and ageing: when are somatic complaints unfounded? Am Psychol 1985; 40(1): 19-28.
60. Stafford L, Berk M, Reddy P, Jackson HJ. Comorbid depression and health-related quality of life in patients with coronary artery disease. J Psychosom Res 2007; 62: 401-410.
61. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005; 28(11): 2668-2672.
62. Egede LE. Effects of depression on work loss and disability bed days in individuals with diabeties. Diabetes Care 2004; 27(7): 1751-1753.
63. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.